|
References
1Magee MJ, Jablonski KA, Stamou SC, Pfister AJ, Dewey TM, Dullum MK, Edgerton JR, Prince SL, Acuff TE, Corso PJ, Mack MJ. Elimination of cardiopulmonary bypass improves early survival for multivessel coronary artery bypass patients. Ann Thorac Surg 2002;73(4):1196-202.
2 Brown PP, Mack MJ, Simon AW, Battaglia S, Tarkington L, Horner S, Culler SD, Becker ER. Outcomes experience with off-pump coronary artery bypass surgery in women. Ann Thorac Surg 2002;74(6):2113-9
3 Plomondon ME, Cleveland JC Jr, Ludwig ST, Grunwald GK, Kiefe CI, Grover FL, Shroyer AL. Off-pump coronary artery bypass is associated with improved risk-adjusted outcomes. Ann Thorac Surg 2001;72(1):114-9.
4 Calafiore AM, Di Mauro M, Canosa C, Cirmeni S, Iaco AL, Contini M, Mazzei V.Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of strategy on midterm outcome. Ann Thorac Surg 2003;76(1):32-6.
5 Zamvar V, Williams D, Hall J, Payne N, Cann C, Young K, Karthikeyan S, Dunne J. Assessment of neurocognitive impairment after off-pump and on-pump techniques for coronary artery bypass graft surgery: prospective randomised controlled trial. BMJ 2002;325(7375):1268.
6Diegeler A, Hirsch R, Schneider F, Schilling LO, Falk V, Rauch T, Mohr FW. Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation. Ann Thorac Surg 2000;69(4):1162-6.
7 Sharony R, Bizekis CS, Kanchuger M, Galloway AC, Saunders PC, Applebaum R, Schwartz CF, Ribakove GH, Culliford AT, Baumann FG, Kronzon I, Colvin SB, Grossi EA. Off-pump coronary artery bypass grafting reduces mortality and stroke in patients with atheromatous aortas: a case control study. Circulation 2003;108(10 Suppl 1):II15-20.
8Stamou SC, Jablonski KA, Pfister AJ, Hill PC, Dullum MK, Bafi AS, Boyce SW, Petro KR, Corso PJ. Stroke after conventional versus minimally invasive coronary artery bypass. Ann Thorac Surg 2002;74(2):394-9.
9Nathoe HM, van Dijk D, Jansen EW, Suyker WJ, Diephuis JC, van Boven WJ, de la Riviere AB, Borst C, Kalkman CJ, Grobbee DE, Buskens E, de Jaegere PP; Octopus Study Group. A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients. N Engl J Med 2003;348(5):394-402.
10Puskas JD, Thourani VH, Marshall JJ, Dempsey SJ, Steiner MA, Sammons BH, Brown WM 3rd, Gott JP, Weintraub WS, Guyton RA. Clinical outcomes, angiographic patency, and resource utilization in 200 consecutive off-pump coronary bypass patients. Ann Thorac Surg 2001;71(5):1477-83
11Biglioli P, Cannata A, Alamanni F, Naliato M, Porqueddu M, Zanobini M, Tremoli E, Parolari A. Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg 2003;24(2):260-9.
12Aldea GS, Soltow LO, Chandler WL, Triggs CM, Vocelka CR, Crockett GI, Shin YT, Curtis WE, Verrier ED. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002;123(4):742-55.
13O'Gara PJ, Natarajan V, Lilly K, Husain A, Shapira OM, Shemin RJ. Clinical outcomes of on-pump coronary bypass using heparin-bonded circuits and reduced anti-coagulation compare favorably with off-pump approach. Perfusion 2002;17(2):91-4.
14Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: Should current practice be changed? J Thorac Cardiovasc Surg 2003;125(6):1438-50.
15DeFoe GR, Ross CS, Olmstead EM, Surgenor SD, Fillinger MP, Groom RC, Forest RJ, Pieroni JW, Warren CS, Bogosian ME, Krumholz CF, Clark C, Clough RA, Weldner PW, Lahey SJ, Leavitt BJ, Marrin CA, Charlesworth DC, Marshall P, O'Connor GT. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2001;71(3):769-76.
16Shapira OM, Aldea GS, Treanor PR, Chartrand RM, DeAndrade KM, Lazar HL, Shemin RJ. Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume. Ann Thorac Surg 1998;65(3):724-30.
17Hammon JW, Stump DA, Kon ND, Cordell AR, Hudspeth AS, Oaks TE, Brooker RF, Rogers AT, Hilbawi R, Coker LH, Troost MD. Risk factors and solutions for the development of neurobehavioral changes after coronary artery bypass grafting. Ann Thorac Surg 1997;63:1613-8.
18Clark RE, Brillman J, Davis DA, Lovell MR, Price TR, Magovern GJ. Microemboli during coronary artery bypass grafting. Genesis and effect on outcome. J Thorac Cardiovasc Surg 1995;109(2):249-57.
19Pugsley W, Klinger L, Paschalis C, Treasure T, Harrison M, Newman S. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke 1994;25(7):1393-9.
20Weerwind PW, Lindhout T, Caberg NE, De Jong DS.Thrombin generation during cardiopulmonary bypass: the possible role of retransfusion of blood aspirated from the surgical field. Thromb J 2003;1(1):3.
21Aldea GS et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002;123:742-55.
22Brooker RF, Brown WR, Moody DM, Hammon JW Jr, Reboussin DM, Deal DD, Ghazi-Birry HS, Stump DA. Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg 1998;65(6):1651-5.
23Koster A, Fischer T, Praus M, Haberzettl H, Kuebler WM, Hetzer R, Kuppe H. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 2002;97(4):837-41.
24Shigeta O, Kojima H, Hiramatsu Y, Jikuya T, Terada Y, Atsumi N, Sakakibara Y, Nagasawa T, Mitsui T. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 118(2):354-360.
25Despotis GJ, Joist JH, Hogue CW Jr, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1995;110(1):46-54.
26Svenmarker S, Haggmark S, Jansson E, Lindholm M, Appelblad M, Sandstrom E, Abert T. Use of heparin-bonded circuits in cardiopulmonary bypass improves clinical outcome. Scand Cardiovasc J 2002;35:241-246.
27Heyer EJ, Lee KS, Manspeizer HE, Mongero L, Spanier TB, Caliste X, Esrig B, Smith C. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction. J Cardiothorac Vasc Anesth 2002;16(1):37-42.
28Kopp R, Mottaghy K, Kirschfink M. Mechanism of complement activation during extracorporeal blood-biomaterial interaction: effects of heparin coated and uncoated surfaces. ASAIO Journal 2002;48:598-605.
29Mahoney CB, Lemole GM. Transfusion after coronary artery bypass surgery: the impact of heparin-bonded circuits. Eur J CardioThorac Surg 1999;16:206-210.
30Mahoney CB. Heparin-bonded circuits: clinical outcomes and costs. Perfusion 1998;13:192-204.
31Aldea GS, Doursounian M, O'Gara P, Treanor P, Shapira OM, Lazar HL, Shemin RJ. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study. Ann Thorac Surg 1996:62:410-8.
32Mahoney CB, Donnelly JE. Impact of closed versus open venous reservoirs on patient outcomes in isolated coronary artery bypass surgery. Perfusion 2000;15:467-472.
33Schonberger JP, Everts PA, Hoffmann JJ. Systemic blood activation with open and closed reservoirs. Ann Thorac Surg 1995;59:1549-55.
34Gourlay T, Samartzis I, Taylor KM. The effect of haemodilution on blood-biomaterial contact-mediated CD11b expression on neutrophils: ex vivo studies. Perfusion 2003;18(2):87-93.
35Gourlay T, Stefanou DC, Asimakopoulos G, Taylor KM. The effect of circuit surface area on CD11b(mac-1) expression in a rat recirculation model. Artif Organs 2001;25(6):475-9.
36Kawahito S, Maeda T, Yoshikawa M, Takano T, Nonaka K, Linneweber J, Mikami M, Motomura T, Ichikawa S, Glueck J, Nose Y. Blood trauma induced by clinically accepted oxygenators. ASAIO J 2001;47(5):492-5.
37Goodin MS, Thor EJ, Haworth WS. Use of computational fluid dynamics in the design of the Avecor Affinity oxygenator. Perfusion 1994;9(3):217-22.
|
